Xinyu Bi

2.6k total citations
100 papers, 1.2k citations indexed

About

Xinyu Bi is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Xinyu Bi has authored 100 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 43 papers in Hepatology and 37 papers in Surgery. Recurrent topics in Xinyu Bi's work include Hepatocellular Carcinoma Treatment and Prognosis (42 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (29 papers) and Pancreatic and Hepatic Oncology Research (12 papers). Xinyu Bi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (42 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (29 papers) and Pancreatic and Hepatic Oncology Research (12 papers). Xinyu Bi collaborates with scholars based in China, United States and Ethiopia. Xinyu Bi's co-authors include Jianqiang Cai, Jianjun Zhao, Jianqiang Cai, Zhen Huang, Jianguo Zhou, Hong Zhao, Jian‐Guo Zhou, Zhiyu Li, Mengchao Wu and Hong Zhao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xinyu Bi

92 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xinyu Bi China	17	480	400	361	316	289	100	1.2k
Bum Jun Kim South Korea	18	536 1.1×	277 0.7×	337 0.9×	294 0.9×	449 1.6×	60	1.1k
Maarten W. Nijkamp Netherlands	17	419 0.9×	361 0.9×	346 1.0×	291 0.9×	126 0.4×	51	1.1k
Ningling Ge China	20	505 1.1×	708 1.8×	323 0.9×	270 0.9×	200 0.7×	44	1.4k
Caterina Vivaldi Italy	18	760 1.6×	207 0.5×	346 1.0×	403 1.3×	512 1.8×	101	1.3k
Shunjun Fu China	17	607 1.3×	421 1.1×	360 1.0×	212 0.7×	174 0.6×	48	1.2k
Cheol-Keun Park South Korea	23	371 0.8×	293 0.7×	682 1.9×	250 0.8×	200 0.7×	48	1.3k
Ingrid Garajová Italy	19	503 1.0×	154 0.4×	404 1.1×	203 0.6×	218 0.8×	82	1.0k
Dulabh Monga United States	15	539 1.1×	158 0.4×	396 1.1×	277 0.9×	227 0.8×	74	1.1k
Weikai Xiao China	18	477 1.0×	213 0.5×	425 1.2×	114 0.4×	265 0.9×	37	1.1k
Margaret M. Kozak United States	19	758 1.6×	164 0.4×	627 1.7×	286 0.9×	320 1.1×	48	1.5k

Countries citing papers authored by Xinyu Bi

Since Specialization

Citations

This map shows the geographic impact of Xinyu Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyu Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyu Bi more than expected).

Fields of papers citing papers by Xinyu Bi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyu Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyu Bi. The network helps show where Xinyu Bi may publish in the future.

Co-authorship network of co-authors of Xinyu Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyu Bi. A scholar is included among the top collaborators of Xinyu Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyu Bi. Xinyu Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Ziqi, et al.. (2025). Analysis of coupled vibrations in low-medium speed high-temperature superconducting maglev train and curved bridge. KSCE Journal of Civil Engineering. 30(2). 100344–100344. 1 indexed citations

Wei, Zhicheng, Bowen Xu, Jianping Chang, et al.. (2024). MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1. Cancer Cell International. 24(1). 129–129. 1 indexed citations

Wang, Yikai, Xinyu Bi, Hong Zhao, et al.. (2023). Prognostic significance of the preoperative alkaline phosphatase‑to‑albumin ratio in patients with hepatocellular carcinoma after hepatic resection. Oncology Letters. 25(4). 147–147. 3 indexed citations

Ke, Qiao, Lei Wang, Ziguo Lin, et al.. (2023). Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysis. BMC Cancer. 23(1). 850–850. 5 indexed citations

Huang, Zhiyong, Meng Yang, Weidong Zhang, et al.. (2023). 181P TQB2450 (PD-L1 blockade) in combination with anlotinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: Primary results from a prospective, single-arm, phase Ib study. Annals of Oncology. 34. S1545–S1545. 1 indexed citations

Meng, Qinghua, Zhenyu Zhu, Juan Li, et al.. (2023). Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition). Chinese Medical Journal. 136(24). 2909–2911. 1 indexed citations

Zhang, Wen, Xinyu Bi, Yongkun Sun, et al.. (2022). Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients. Clinical Cancer Research. 28(16). 3499–3508. 42 indexed citations

Lin, Xu, et al.. (2022). Survival of Patients Subjected to Hepatectomy After Spontaneous Rupture of Hepatocellular Carcinoma: A Meta-analysis of High-quality Propensity Score Matching Studies. Frontiers in Oncology. 12. 877091–877091. 4 indexed citations

Sun, Yongkun, Aiping Zhou, Wen Zhang, et al.. (2021). Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study). Hepatology International. 15(3). 621–629. 41 indexed citations

10.

Li, Xingchen, Xinyu Bi, Zhiyu Li, et al.. (2021). A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma. Translational Cancer Research. 10(4). 1773–1786. 5 indexed citations

11.

Chen, Xiao, Zhen Huang, Jianjun Zhao, et al.. (2020). <p>Clinical Analysis of 15 Cases of Gallbladder Neuroendocrine Carcinoma and Comparison with Gallbladder Adenocarcinoma Using a Propensity Score Matching</p>. Cancer Management and Research. Volume 12. 1437–1446. 18 indexed citations

12.

Bi, Xinyu & Zhiwen Luo. (2020). 1967P Comprehensive analysis of a microvascular invasion related ceRNA network reveals a potential prognostic lncRNAs signature involved in hepatocellular carcinoma progression and sorafenib resistance. Annals of Oncology. 31. S1106–S1106.

13.

Chen, Kun, Zhiyuan Wu, Hong Zhao, et al.. (2019). XCL1 / Glypican-3 Fusion Gene Immunization Generates Potent Antitumor Cellular Immunity and Enhances Anti–PD-1 Efficacy. Cancer Immunology Research. 8(1). 81–93. 34 indexed citations

14.

Cheng, Shuqun, Minshan Chen, Jianqiang Cai, et al.. (2019). Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition). Liver Cancer. 9(1). 28–40. 114 indexed citations

15.

Chen, Qichen, Cong Li, Yang Han, et al.. (2019). Resection Combined with TKI Therapy for Resectable Liver Metastases of Gastrointestinal Stromal Tumours: Results from Three National Centres in China. Journal of Gastrointestinal Surgery. 24(6). 1330–1341. 4 indexed citations

16.

Peng, Li, Binyuan Jiang, Xiaoqing Yuan, et al.. (2018). Super-Enhancer–Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma. Cancer Research. 79(3). 572–584. 109 indexed citations

17.

Zeng, Fanxin, Xiao Chen, Wei Wen, et al.. (2018). RIPK1 Binds MCU to Mediate Induction of Mitochondrial Ca2+ Uptake and Promotes Colorectal Oncogenesis. Cancer Research. 78(11). 2876–2885. 70 indexed citations

18.

Chen, Qichen, Xiaohong Chen, Haizhen Lu, et al.. (2018). Primary hepatic neuroendocrine tumors: retrospective analysis of seven cases and literature review. Translational Cancer Research. 7(2). 428–440. 1 indexed citations

19.

Zhou, Aiping, et al.. (2017). Efficacy of Topical Compound Danxiong Granules for Treatment of Dermatologic Toxicities Induced by Targeted Anticancer Therapy: A Randomized, Double‐Blind, Placebo‐Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2017(1). 3970601–3970601. 8 indexed citations

20.

Yan, Tao, Xinyu Bi, Yi Fang, et al.. (2012). Adiuvant huaier on long-term survivals after curative hepatectomy for primary liver cancer. Zhonghua gan-dan waike zazhi. 18(2). 99–102. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact